Sort   by:  
 Page size 
UnknownImmunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line.
Not available
S-EPMC6685516 | biostudies-literature
UnknownEarly BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
Not available
S-EPMC5279791 | biostudies-literature
UnknownGlucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study.
Not available
S-EPMC7145777 | biostudies-literature
UnknownIFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.
Not available
S-EPMC9433106 | biostudies-literature
UnknownAssociation between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies.
Not available
S-EPMC3156338 | biostudies-literature
UnknownGenetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies.
Not available
S-EPMC10034922 | biostudies-literature
UnknownMultiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions.
Not available
S-EPMC6545280 | biostudies-literature
Sort   by:  
 Page size